Position in TBPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$488,880
-$726,439 QoQ
Shares Held
30,122
-74.9% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,071,812,333 across 189 Biotechnology names. TBPH ranks #173 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,000,428 | $65,938,209 |
All Filings in TBPH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $488,880 | 30,122 | Shares | Sole | 2026-05-15 | |
| 2022-09-30 | $1,215,319 | 119,854 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,325,865 | 2,243,473 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,682,802 | 1,326,653 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,354,998 | 575,113 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,645,562 | 1,979,130 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,443,722 | 374,912 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||